Mayo Clinic Cardiology.pdf

Mayo Clinic Cardiology

Concise Textbook

THIRD EDITION

Mayo Clinic Cardiology

Concise Textbook

THIRD EDITION

Editors

Joseph G. Murphy, MD

Margaret A. Lloyd, MD

Associate Editors

Gregory W. Barsness, MD

Arshad Jahangir, MD

Garvan C. Kane, MD

Lyle J. Olson, MD

MAYO CLINIC SCIENTIFIC PRESS

AND INFORMA HEALTHCARE USA, INC.

ISBN 0-8493-9057-5

The triple-shield Mayo logo and the words MAYO, MAYO CLINIC,

and MAYO CLINIC SCIENTIFIC PRESS are marks of Mayo Foundation

for Medical Education and Research.

be reproduced, stored in a retrieval system, or transmitted, in any form or

by any means—electronic, mechanical, photocopying, recording, or

otherwise—without the prior written consent of the copyright holder,

except for brief quotations embodied in critical articles and reviews.

Inquiries should be addressed to Scientific Publications, Plummer 10,

Mayo Clinic, 200 First Street SW, Rochester, MN 55905.

For order inquiries, contact Taylor & Francis Group, 6000 Broken Sound

Parkway NW, Suite #300, Boca Raton, FL 33487.

www.taylorandfrancis.com

Catalog record is available from the Library of Congress.

Care has been taken to confirm the accuracy of the information presented

and to describe generally accepted practices. However, the authors, editors,

and publisher are not responsible for errors or omissions or for any con-

sequences from application of the information in this book and make no

warranty, express or implied, with respect to the contents of the publica-

tion. This book should not be relied on apart from the advice of a qual-

ified health care provider.

The authors, editors, and publisher have exerted efforts to ensure that

drug selection and dosage set forth in this text are in accordance with cur-

rent recommendations and practice at the time of publication. However,

in view of ongoing research, changes in government regulations, and the

constant flow of information relating to drug therapy and drug reactions,

the reader is urged to check the package insert for each drug for any change

in indications and dosage and for added warnings and precautions. This

is particularly important when the recommended agent is a new or infre-

quently employed drug.

Some drugs and medical devices presented in this publication have

Food and Drug Administration (FDA) clearance for limited use in restrict-

ed research settings. It is the responsibility of the health care providers to

ascertain the FDA status of each drug or device planned for use in their clin-

ical practice.

Printed in Canada

10 9 8 7 6 5 4 3 2

Plik z chomika:

Inne pliki z tego folderu:

Inne foldery tego chomika: